Deschatelets Pascal — SEC Form 4 filings

SEC reporting owner CIK 1657720. 19 Form 4 filings on record with FilingPulse; latest filed 2026-05-14.

Transaction summary — filings shown

Covers all 19 filings on record, filed 2024-01-17 to 2026-05-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Apellis Pharmaceuticals, Inc. (APLS)Chief Scientific Officer1919 legs · 241,614 sh · $12,310,39937

Form 4 filings — Deschatelets Pascal

FiledFormIssuerReported transactionsSource
2026-05-144Apellis Pharmaceuticals, Inc. (APLS)Code (U): 1,177,222 · Grant/award (A): 41,250 · Disposition to issuer (D): 41,250 · Grant/award (A): 10,030 · Disposition to issuer (D): 10,030 · Grant/award (A): 12,920 · +16 moreEDGAR
2026-01-304Apellis Pharmaceuticals, Inc. (APLS)Grant/award (A): 25,840 @ $0EDGAR
2026-01-234Apellis Pharmaceuticals, Inc. (APLS)Sale (S): 5,928 @ $21.77EDGAR
2026-01-214Apellis Pharmaceuticals, Inc. (APLS)Sale (S): 909 @ $19.79EDGAR
2026-01-154Apellis Pharmaceuticals, Inc. (APLS)Sale (S): 2,277 @ $22.19EDGAR
2025-06-114Apellis Pharmaceuticals, Inc. (APLS)Grant/award (A): 82,500 (derivative) @ $19.39EDGAR
2025-05-224Apellis Pharmaceuticals, Inc. (APLS)Option exercise (M): 12,780 @ $3.76 · Option exercise (M): 12,780 (derivative) @ $0EDGAR
2025-01-304Apellis Pharmaceuticals, Inc. (APLS)Sale (S): 826 @ $29.52EDGAR
2025-01-234Apellis Pharmaceuticals, Inc. (APLS)Sale (S): 3,948 @ $30.43EDGAR
2025-01-214Apellis Pharmaceuticals, Inc. (APLS)Sale (S): 750 @ $29.96 · Grant/award (A): 15,045 @ $0EDGAR
2025-01-144Apellis Pharmaceuticals, Inc. (APLS)Sale (S): 2,288 @ $28.70EDGAR
2024-05-214Apellis Pharmaceuticals, Inc. (APLS)Option exercise (M): 24,500 @ $3.76 · Option exercise (M): 24,500 (derivative) @ $0EDGAR
2024-05-094Apellis Pharmaceuticals, Inc. (APLS)Option exercise (M): 78,907 @ $4.31 · Sale (S): 56,335 @ $42.15 · Sale (S): 22,472 @ $42.85 · Sale (S): 100 @ $44.02 · Option exercise (M): 78,907 (derivative) @ $0EDGAR
2024-04-094Apellis Pharmaceuticals, Inc. (APLS)Option exercise (M): 69,107 @ $3.76 · Sale (S): 64,379 @ $54.12 · Sale (S): 4,728 @ $54.92 · Option exercise (M): 69,107 (derivative) @ $0EDGAR
2024-03-114Apellis Pharmaceuticals, Inc. (APLS)Option exercise (M): 69,107 @ $3.67 · Sale (S): 42,750 @ $61.88 · Sale (S): 26,257 @ $62.69 · Sale (S): 100 @ $63.35 · Option exercise (M): 69,107 (derivative) @ $0EDGAR
2024-02-134Apellis Pharmaceuticals, Inc. (APLS)Sale (S): 1,148 @ $67.77EDGAR
2024-01-314Apellis Pharmaceuticals, Inc. (APLS)Sale (S): 874 @ $64.14EDGAR
2024-01-234Apellis Pharmaceuticals, Inc. (APLS)Sale (S): 3,913 @ $65.00EDGAR
2024-01-174Apellis Pharmaceuticals, Inc. (APLS)Grant/award (A): 6,743 @ $0 · Sale (S): 1,632 @ $66.81 · Grant/award (A): 9,805 (derivative) @ $66.30EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1657720 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →